Disorder "Cystic fibrosis"
Found 271 records
Disorder information
Disorder name:
Cystic fibrosis
Disoder ID:
OMIM entry:
Synonyms:
CF,mucoviscidosis
Definition:
Cystic fibrosis (CF) is a genetic disorder characterized by the production of sweat with a high salt content and mucus secretions with an abnormal viscosity.
Modifier statisitcs
Record:
271
Gene:
86
Variant:
197
Reference:
76
Effect type:
Expressivity(157)
,Pleiotropy(82)
,Penetrance(32)
Modifier effect:
Altered severity(64)
,Altered phenotype(52)
,Risk factor(44)
,Altered incidence(30)
,Altered FEV1 level(12)
,Altered lung function(7)
,Altered life span(6)
,Altered the contributing organ(5)
,Altered susceptibility(4)
,Altered FEV(1)(4)
,CFTR mediated residual chloride secretion(4)
,Altered Ca2+-influx(3)
,Altered Pseudomonas aeruginosa colonization rate(3)
,Altered onset time(3)
,Age-adjusted lung function(2)
,Altered CF-associated pulmonary inflammation(2)
,Altered gene activity(2)
,Altered onset time of P. aeruginosa airway infection(2)
,Altered pulmonary function(2)
,Altered epithelial chloride secretion(1)
,Altered lung disease progression(1)
,Altered RhoA activity(1)
,Altered X ray score (Chrispin-Norman) and Shwachman score(1)
,Altered acute phase levels(1)
,Altered airway nitric oxide formation(1)
,Altered annual rate of FEV1(1)
,Altered chance of developing portal hypertension(1)
,Altered forced vital capacity and risk of MI or DIOS(1)
,Altered gene activity and Altered severity(1)
,Altered intestinal secretion(1)
,Altered onset time and altered severity(1)
,Altered pulmonary prognosis(1)
,Altered rates of CFRD(1)
,Altered response to pulmonary infection with Pa(1)
,Altered risk of chronic Pseudomonas aeruginosa infection(1)
,Altered variability of FENO and P. aeruginosa colonization(1)
,Anti-inflammatory target(1)
,Prevention of disease(1)
,Protective effect against severe pulmonary disease(1)
Modifier gene | Variant | Effect type | Modifier effect | Evidence | Effect | PubMed ID |
---|---|---|---|---|---|---|
SERPINA1 | SERPINA1:c.1096G>A(p.Glu366Lys) | Expressivity | Altered severity | OR=4.72; 95% CI: 2.31-9.61; P=3.3×10(-6) | Patients who carry the Z allele are at greater risk of developing severe liver disease with portal hypertension.more | more |
SERPINA1:c.1237G>A | Expressivity | Altered acute phase levels | From review article | 1237G>A in the 3′untranslated region, which may result in a decrease in acute phase levelsmore | more | |
SERPINA1:c.4627G>A | Expressivity | Altered severity | Gene activity study | Deficiency of alpha 1-AT is not associated with more severe pulmonary disease in cystic fibrosis and may be associated with milder lung disease.more | more | |
SERPINA1:c.863A>T(p.Glu288Val) | Expressivity | Altered severity | Gene activity study | Deficiency of alpha 1-AT is not associated with more severe pulmonary disease in cystic fibrosis and may be associated with milder lung disease.more | more | |
SERPINA1:p.Glu264Val | Expressivity | Altered severity | From review article | Glu264Val or c2313T>A and Glu342Lys or c4627G>A reduced plasma levels of α1-antitrypsin,affect lung disease or nutritional status and have mixed results regarding infection status and liver disease.more | more | |
SERPINA1:p.Glu342Lys | Expressivity | Altered severity | From review article | Glu264Val or c2313T>A and Glu342Lys or c4627G>A reduced plasma levels of α1-antitrypsin,affect lung disease or nutritional status and have mixed results regarding infection status and liver disease.more | more | |
SERPINA1:p.Gly264Val | Expressivity | Risk factor | From review article | The mutation associated with Gilbert syndrome represents a lithogenic risk factor for gallstone formation in CFmore | more | |
SERPINA1:p.Gly342Leu | Expressivity | Risk factor | From review article | The mutation associated with Gilbert syndrome represents a lithogenic risk factor for gallstone formation in CFmore | more | |
SERPINA1 | Pleiotropy | Altered Pseudomonas aeruginosa colonization rate | From review article | Higher FEV1 and fewer colonized with Pseudomonas aeruginosa for deficient patientsmore | more | |
SERPINA1 | Expressivity | Risk factor | From review article | Association observed in ≥2 independent populations with ≥500 participants in aggregatemore | more |